![16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate structure](/static/products/2025/20258-77-9.webp)
16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate
TL;DR: 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate (CAS 20258-77-9) is a chemical compound with molecular formula C30H45BrN2O2 and molecular weight 544.27 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
[16-bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
Also Known As: 16-bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate, [16-bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate, 16-Bromo-20-(1-cyano-5-methylpiperidin-2-yl)pregn-5-en-3-yl acetate
| Molecular Formula | C30H45BrN2O2 |
|---|---|
| Molecular Weight | 544.27 g/mol |
| LogP | 7.9 |
| Topological Polar Surface Area | 53.3 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Exact Mass | 544.2664 |
| Heavy Atoms | 35 |
| Complexity | 925.0 |
Chemical Identifiers
| CAS Number | 20258-77-9 |
|---|---|
| SMILES | CC1CCC(N(C1)C#N)C(C)C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC(=O)C)C)C)Br |
| InChIKey | OXEZESWCAIDKNU-UHFFFAOYSA-N |
Product Overview
16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate (CAS 20258-77-9), with molecular formula C30H45BrN2O2 and molecular weight 544.27 g/mol. IUPAC: [16-bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate.
Chemical Property Profile of 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate
Property Insights of 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate
The XLogP value of 7.9 indicates that 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 53.3 Ų, 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate has 0 hydrogen bond donor(s) and 4 hydrogen bond acceptor(s), which may warrant consideration for formulation optimization.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate?
The CAS number of 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate is 20258-77-9.
What is the molecular formula of 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate?
The molecular formula of 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate is C30H45BrN2O2.
What is the molecular weight of 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate?
The molecular weight of 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate is 544.27 g/mol.
Where can I buy 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate?
You can request a quote for 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate?
Yes, KEHONG BIO provides custom synthesis services for 16-Bromo-17-[1-(1-cyano-5-methylpiperidin-2-yl)ethyl]androst-5-en-3-yl acetate and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.